RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Undecimal Bio

Undecimal Bio

Undecimal pairs massive scale combinatorial chemistry with transformer-based AI to guide siRNA therapeutics into the tissues that need them.

Latest funding

$18M Seed ·

Source: allsci.com

Funding history ↓
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Life Science.
Stage: Seed.
Based in: Ramat Gan, Israel.
Last round: Oct 13, 2026 · 10 days ago.
Domain age: 16 months.
On Recent Funding since: Oct 13, 2026.
About Undecimal Bio

Undecimal Bio is a company based in Ramat Gan, Israel. Recent Funding lists it under Health and bio. It raised $18M in a Seed round in October 2026, according to allsci.com. Investors on record include 4BIO Capital, Entrée Capital, Harel Insurance and Financial, IQ Capital and 3 others. It was founded by Yaniv Erlich and Shaul Ilan.

Funding rounds

  1. Seed · $18M
    Source: allsci.com
  2. Website created

Founders and team

Investors

Similar Health and bio companies

Questions and sources

Undecimal Bio: questions and answers

How much has Undecimal Bio raised?
Undecimal Bio has raised $18M in one sourced round on record (Seed), announced October 13, 2026.
Who invested in Undecimal Bio?
Investors on record for Undecimal Bio: 4BIO Capital, Entrée Capital, Harel Insurance and Financial, IQ Capital, Kerna Ventures, Saras Capital and Verve Ventures.
Who founded Undecimal Bio?
Undecimal Bio was founded by Yaniv Erlich (Co-founder and CEO) and Shaul Ilan (Co-founder and COO).
Where is Undecimal Bio based?
Undecimal Bio is based in Ramat Gan, Israel.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/undecimal-bio (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy